ACI's 14th National Pharmaceutical Compliance & Enforcement Forum

20 March 2014 Philadelphia, PA Past Event

Location

The Union League
140 South Broad Street
Philadelphia, PA

Agenda

March 19-20, 2014
Partner Judith Waltz is moderating a panel discussion titled “CIA Focus Group – Identifying Compliance Issues; Best Methods to Respond to an Investigation; Discussing Negotiation Tactics to Create Feasible Conditions,” at the American Conference Institute’s 14th National Pharmaceutical Compliance & Enforcement Forum on March 20, 2014.

Topics to be discussed include:

  • Lessons to be learned from recent CIA agreements: Separating out individual considerations and identifying across-the-board negotiation points
    • How much of your global and domestic business will be covered by the CIA?
    • What kind of monitoring controls and systems need to be implemented?
    • What kind of restraints on HCP relationships can you enter into?
  • What trends about OIG priorities can be extrapolated from recent CIAs?
  • Determining the ramifications of multi-violators
  • Distinguishing between boiler-plate and investigation specific provisions
    • What provisions are subject to modification based on company specific factors?
    • Insights into what provisions have been successfully tailored by other companies
  • Creating a cooperative relationship with your appointed monitors and communicating effectively with the OIG during the pendency of the CIA
  • Proactively fortifying your compliance system based on the requirements of other pharmaceutical and medical device CIAs before negotiating with the government
  • Living under a CIA
    • Understanding the effects
    • Getting the Board of Directors involved
    • Discussing the likelihood of “probation” becoming a new standard
  • Preparing for potential tax consequences to settlements – distinguishing between repayments and penalties
    • Evaluating what constitutes a “reportable event”
    • Setting up internal review organizations and data collection as to implementation of programs
  • Preparing for allegations of a breach
    • Identifying who can enforce CIA conditions
    • Comparing jurisdictional views on whether a breach of a CIA can give rise to an action under the False Claims Act
    • Updating investigators on what systems have been implemented and providing data on efficacy
    • Retaining independent review organizations

For more information, visit the event website.

Related Services

Insights

Cryptocurrency in China is like BIG BROTHER in 1984!
20 October 2019
Internet, IT & e-Discovery Blog
California Governor Signs New Telehealth Insurance Law
18 October 2019
Health Care Law Today
Continued Increase in E-Commerce and Online Ordering Changes Landscape of Urban Transportation
17 October 2019
Dashboard Insights
CMS Proposes Revisions to Stark Law
16 October 2019
Health Care Law Today
PATH Summit 2019
18-20 December 2019
Arlington, VA
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.

ACI's 14th National Pharmaceutical Compliance & Enforcement Forum

Location

The Union League
140 South Broad Street
Philadelphia, PA

Agenda

March 19-20, 2014